Literature DB >> 2260158

Drug-resistant malaria: mechanisms of development and inferences for malaria control.

A Björkman1, P A Phillips-Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260158     DOI: 10.1016/0035-9203(90)90302-u

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  7 in total

Review 1.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  An overview of the malaria situation in Zanzibar.

Authors:  E Schwartz; H Pener; S M Issa; J Golenser
Journal:  J Community Health       Date:  1997-02

3.  Antimalarial drug utilization by women in Ethiopia: a knowledge-attitudes-practice study.

Authors:  H Yeneneh; T W Gyorkos; L Joseph; J Pickering; S Tedla
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

4.  Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro.

Authors:  S T Mariga; J P Gil; C Sisowath; W H Wernsdorfer; A Björkman
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

6.  Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China.

Authors:  D Q Liu; R J Liu; D X Ren; D Q Gao; C Y Zhang; C P Qui; X Z Cai; C F Ling; A H Song; X Tang
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

7.  In vitro antiplasmodial, antiamoebic, and cytotoxic activities of a series of bisbenzylisoquinoline alkaloids.

Authors:  S J Marshall; P F Russell; C W Wright; M M Anderson; J D Phillipson; G C Kirby; D C Warhurst; P L Schiff
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.